** Shares of Monash IVF Group MVF.AX rise 4.7% to A$1.22
** Stock hits highest level since mid-January
** The fertility services provider posts 1H25 underlying NPAT of A$15.8 million, up 5.5% from previous year
** Co expects to record underlying group NPAT between A$30 million and A$31 million in FY25 compared to A$29.9 million in FY24
** Co posts 1H25 revenue growth of 11.6% to A$10.3 million
** About 810,200 shares change hands, 1.3 times the 30-day average volume of shares
** Stock down 8.3% this year, as of last close
(Reporting by Sherin Sunny in Bengaluru)
((Sherin.Sunny@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。